A Clinical Study for the Effect of 4th Generation Poly AmidoAmine Dendrimer on Post-Bleaching Hypersensitivity and Shade Stability
NCT ID: NCT06358911
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2021-11-13
2023-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Desensitizing Agents on Post-bleaching Hypersensitivity and Shade Stability
NCT06358924
Hypersensitivity and Color Changes of Bleached Teeth Using Different Remineralizing Agents
NCT04875000
Three Different Topically Applied Materials as Non-invasive Treatment of Sensitivity in Permanent Teeth With Molar Incisor Hypomineralization
NCT07056855
The Remineralization of Early Enamel Caries in Permanent Teeth
NCT06358066
Regenerative Endodontic in Immature Permanent Teeth
NCT06006052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Long-term Post-bleaching hypersensitivity.
2. Long-term Post-bleaching shade stability. For Patients treated with 40% hydrogen-peroxide bleaching agent.
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Poly amido amine dendrimer (PAMAM)'s desensitizing agent
Fourth generation with COOH terminal functional group, colorless liquid. PAMAM-succinamic acid dendrimer, 1,4-diaminobutane core, generation 4 solution. 10 wt.% in water.
The application of PAMAM 30 min according to previous studies
Poly amido amine dendrimer (PAMAM)
Desensitizing agents was applied once after the bleaching procedure,as follows:
1-Bleaching/PAMAM group, patients received bleaching followed by the application of PAMAM for 30 minutes according to previous studies.
Manufacturer's desensitizing agent, Ultra EZ
3% potassium nitrate and 0.11% fluoride (Ultra EZ), gel The application of manufacturer recommended desensitizing agent for 1hrs
Manufacturer's desensitizing agent, Ultra EZ
Desensitizing agents was applied once after the bleaching procedure, as follows:
2-Control group, where patients received hydrogen peroxide in-office bleaching followed by the application of manufacturer recommended desensitizing agent ( Ultra EZ) once for 60 minutes.
MI paste plus, desensitizing agent
Casein-phosphopeptide-amorphous calcium phosphate with Fluoride, topical tooth cream.
Gel contains pure water,D-sorbitol,glycerol,Carboxymethylcellulose Sodium, casein phosphopeptide amorphous calcium phosphate,propylene glycol, titanium dioxide, Silicon dioxide, Sodium Saccharin,Phosphoric acid, butyl P-hydroxy-benzoate, and ethyl hydroxyl benzoate
The application of MI paste plus according to manufacturer instructions, 3minutes
MI paste plus, desensitizing agent
Desensitizing agents was applied once after the bleaching procedure, as follows:
3-Bleaching/MI Paste Plus group, patients received bleaching followed by the application of MI paste plus according to the manufacturer's instructions once for 3 minutes.
Hydroxyapatite and F (ReminPro), desensitizing agent
Hydroxyapatite, Fluoride and Xylitol, water-based cream The application of Hydroxyapatite and F (ReminPro) according to manufacturer instructions, 3minutes
Hydroxyapatite and F (ReminPro), desensitizing agent
Desensitizing agents was applied once after the bleaching procedure, as follows:
4-Bleaching/Hydroxyapatite and F (ReminPro), patients received bleaching followed by the application of Hydroxyapatite and F (ReminPro) according to the manufacturer's instructions once for 3 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Poly amido amine dendrimer (PAMAM)
Desensitizing agents was applied once after the bleaching procedure,as follows:
1-Bleaching/PAMAM group, patients received bleaching followed by the application of PAMAM for 30 minutes according to previous studies.
Manufacturer's desensitizing agent, Ultra EZ
Desensitizing agents was applied once after the bleaching procedure, as follows:
2-Control group, where patients received hydrogen peroxide in-office bleaching followed by the application of manufacturer recommended desensitizing agent ( Ultra EZ) once for 60 minutes.
MI paste plus, desensitizing agent
Desensitizing agents was applied once after the bleaching procedure, as follows:
3-Bleaching/MI Paste Plus group, patients received bleaching followed by the application of MI paste plus according to the manufacturer's instructions once for 3 minutes.
Hydroxyapatite and F (ReminPro), desensitizing agent
Desensitizing agents was applied once after the bleaching procedure, as follows:
4-Bleaching/Hydroxyapatite and F (ReminPro), patients received bleaching followed by the application of Hydroxyapatite and F (ReminPro) according to the manufacturer's instructions once for 3 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Teeth have never been bleached before.
* The participants are required to have low-caries index.
* Teeth should have a Vita-color shade of A2 or darker.
* Cooperative behavior patient and medically free.
* Patient ages between 18 to 40 years old.
Exclusion Criteria
* Smoking, alcoholism.
* Hypersensitivity to the agents used in the study.
* Lactated, pregnant patients.
* Patients have serious oral diseases, as acute necrotizing gingivitis, acute gingiva stomatitis, or undergoing orthodontic treatment.
* Patients with dental enamel cracks.
* Patients who had previous bleaching treatments
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Farid MS Al Askary, Professor
Role: STUDY_DIRECTOR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry - Ain Shams University
Cairo, El Weili, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDASU-RecID022001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.